Correlation Between Clal Biotechnology and Pluristem

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Clal Biotechnology and Pluristem at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Clal Biotechnology and Pluristem into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Clal Biotechnology Industries and Pluristem, you can compare the effects of market volatilities on Clal Biotechnology and Pluristem and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Clal Biotechnology with a short position of Pluristem. Check out your portfolio center. Please also check ongoing floating volatility patterns of Clal Biotechnology and Pluristem.

Diversification Opportunities for Clal Biotechnology and Pluristem

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Clal and Pluristem is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Clal Biotechnology Industries and Pluristem in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pluristem and Clal Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Clal Biotechnology Industries are associated (or correlated) with Pluristem. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pluristem has no effect on the direction of Clal Biotechnology i.e., Clal Biotechnology and Pluristem go up and down completely randomly.

Pair Corralation between Clal Biotechnology and Pluristem

Assuming the 90 days trading horizon Clal Biotechnology Industries is expected to generate 0.42 times more return on investment than Pluristem. However, Clal Biotechnology Industries is 2.38 times less risky than Pluristem. It trades about 0.1 of its potential returns per unit of risk. Pluristem is currently generating about -0.32 per unit of risk. If you would invest  4,450  in Clal Biotechnology Industries on January 26, 2024 and sell it today you would earn a total of  190.00  from holding Clal Biotechnology Industries or generate 4.27% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy93.75%
ValuesDaily Returns

Clal Biotechnology Industries  vs.  Pluristem

 Performance 
       Timeline  
Clal Biotechnology 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Clal Biotechnology Industries are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak forward indicators, Clal Biotechnology sustained solid returns over the last few months and may actually be approaching a breakup point.
Pluristem 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Pluristem are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Pluristem sustained solid returns over the last few months and may actually be approaching a breakup point.

Clal Biotechnology and Pluristem Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Clal Biotechnology and Pluristem

The main advantage of trading using opposite Clal Biotechnology and Pluristem positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Clal Biotechnology position performs unexpectedly, Pluristem can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pluristem will offset losses from the drop in Pluristem's long position.
The idea behind Clal Biotechnology Industries and Pluristem pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.

Other Complementary Tools

Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum